Genvax Technologies is a startup animal vaccine company located in Ames, Iowa. We have a dynamic team of experienced scientists and entrepreneurs poised to develop next generation mRNA + nanoparticle vaccines. This isn’t the first go-around for co-founders Joel Harris and Dr. Hank Harris, who successfully created, grew and sold Harrisvaccines to Merck Animal Health in 2015. We are focused on developing novel vaccines for the prevention and treatment of animal diseases. We cultivate new ideas to make our world a better place and strive to create a long-lasting impact on animal health world-wide.We believe in rapidly responding to the world around us. We are Genvax and we are committed to making the world a better place.